You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1818441 |
---|---|
Category | Antibodies |
Description | Recombinant Antibody |
Clonality | Monoclonal |
Tested applications | ELISA, FC |
Reactivity | Human, Mouse, Rat |
Isotype | IgG1 |
Antibody Type | Primary Antibody |
Concentration | 1mg/ml |
Form/Appearance | Purified monoclonal antibody supplied in PBS, pH 6.0, without preservative.This antibody is purified through a protein A column. |
Conjugation | Unconjugated |
MW | 145.44 |
UniProt ID | P04626 |
Protein Sequence | ERBB2 / HER2 / CD340 |
Expression System | CHO Cell |
Endotoxins | < 0.001EU/μg,determined by LAL method. |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles |
Alternative names | Receptor tyrosine-protein kinase erbB-2, 2.7.10.1, Read more... |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
The purity of Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) is more than 99.02%, determined by SEC-HPLC.
Immobilized human HER2 (23 652) His at 2 µg/mL can bind Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab), EC50=0.01375 µg/mL
Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%
Pertuzumab+trastuzumab inhibited the tumor growth of NCI-N87 on Balb/c nude mice. The result showed significant anti-tumor effects, with an tumor inhibition rate (TGI) of 73.8% at 5 mpk at D37.
BT474 cells were stained with Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC98=0.2994 µg/mL
ELISA, FA, FACS, Kinetics | |
Human | |
Monoclonal | |
Unconjugated |